Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

6 Downloads (Pure)

Original language	English
Pages (from-to)	279-289
Number of pages	11
Journal	Cancer Management and Research (online)
Volume	2015
Issue number	7
DOIs	https://doi.org/10.2147/CMAR.S79258
Publication status	Published - 2015

Access to Document

@article{ac255246b27644139e779c5fdf5f9304,

title = "Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine",

author = "Olena Mandrik and {Corro Ramos}, Isaac and Saskia Knies and Maiwenn Al and Hans Severens",

year = "2015",

doi = "10.2147/CMAR.S79258",

language = "English",

volume = "2015",

pages = "279--289",

journal = "Cancer Management and Research",

issn = "1179-1322",

publisher = "Dove Medical Press Ltd.",

number = "7",

}

TY - JOUR

T1 - Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine

AU - Mandrik, Olena

AU - Corro Ramos, Isaac

AU - Knies, Saskia

AU - Al, Maiwenn

AU - Severens, Hans

PY - 2015

Y1 - 2015

U2 - 10.2147/CMAR.S79258

DO - 10.2147/CMAR.S79258

M3 - Article

SN - 1179-1322

VL - 2015

SP - 279

EP - 289

JO - Cancer Management and Research

JF - Cancer Management and Research

IS - 7

ER -